TITLE

Thyroid Arterial Embolization to Treat Graves' Disease

AUTHOR(S)
Zhao, W.; Gao, B. -L.; Yang, H. -Y.; Li, H.; Song, D. -P.; Xiang, S. -T.; Shen, J.
PUB. DATE
February 2007
SOURCE
Acta Radiologica;Feb2007, Vol. 48 Issue 2, p186
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
Purpose: To prospectively investigate the effect of thyroid arterial embolization on hyperthyroid Graves' disease in selected patients. Material and Methods: Twenty-eight patients with hyperthyroidism caused by Graves' disease were enrolled to undergo thyroid arterial embolization and followed up for 12-22 months. Twenty-two patients had three thyroid arteries embolized and six patients two arteries. Serum thyroid hormone, thyroid-stimulating hormone (TSH), and autoimmune function were tested before and after embolization in all patients. Results: Of 28 patients, 22 (78.6%) became euthyroid, five improved (17.8%), and one had temporary improvement followed by recurrence (3.6%). No serious complications occurred. Compared with the pre-embolization values, serum concentrations of thyroid hormone increased temporarily on day 3 post-embolization, dropped substantially after 1 and 2 months, and returned to nearly normal at 6 and 12 months post-embolization. TSH dropped on day 3, increased after 1 and 2 months, and returned to normal after 6 and 12 months. Thyroid antibodies TGAb and TMAb declined on day 3 to normal range, rose after 1 month, dropped to normal again after 2 months, and were slightly increased at 6 and 12 months follow-up. Conclusion: Thyroid arterial embolization may be an effective approach for patients with hyperthyroidism caused by Graves' disease.
ACCESSION #
24280228

 

Related Articles

  • Graves' disease.  // Taber's Cyclopedic Medical Dictionary (2009);2009, Issue 21, p984 

    An encyclopedia entry for "Graves' disease" is presented. It refers to a type of hyperthyroidism caused by an autoimmune destruction of the thyroid gland. It increases the production of thyroxine, produces enlargement of the thyroid gland and my cause ocular findings. It symptoms include...

  • Psychiatric Manifestations of Graves’ Hyperthyroidism: Pathophysiology and Treatment Options. Bunevicius, Robertas; Prange, Arthur J. // CNS Drugs;2006, Vol. 20 Issue 11, p897 

    Graves’ disease is an autoimmune disorder that is the most common cause of hyperthyroidism. Other symptoms associated with the disease are goitre, ophthalmopathy, and psychiatric manifestations such as mood and anxiety disorders and, sometimes, cognitive dysfunction. Graves’...

  • Hyperthyroidism: Current Treatment Guidelines. Gittoes, N.J.L.; Franklyn, J.A. // Drugs;Apr1998, Vol. 55 Issue 4, p543 

    Hyperthyroidism is common and affects approximately 2% of women and 0.2% of men. The most common cause of hyperthyroidism is Graves' disease, an autoimmune disorder associated with circulating immunoglobulins that bind to and stimulate the thyrotropin (TSH) receptor, resulting in sustained...

  • Thyroid trouble. Hynes, Angela // Natural Health;Dec2010/Jan2011, Vol. 41 Issue 1, p54 

    The article presents information on the issues related to hypothyroidism and hyperthyroidism. Hypothyroidism is characterized by deficiency of thyroid hormone and its risk increases during pregnancy and with age. Its symptoms include weight gain, dry skin and constipation. Levothyroxine is...

  • A Swelling in the Neck. Leung, Alexander K. C.; Pacaud, Daniéle // American Family Physician;5/15/2006, Vol. 73 Issue 10, p1793 

    Presents information on Graves' disease. Medical history of a patient with the disease; Symptoms and physical examination signs of the disease; Information on other types of thyroid gland diseases.

  • GRAVES' ORBITOPATHY: IS THERE SOMETHING NEW? Bartalena, Luigi // Medicinski Glasnik / Medical Gazette;2012, Vol. 17 Issue 44S, p37 

    Graves' orbitopathy (GO) is the most important extrathyroidal manifestation of Graves' disease. It is an invalidating disease profoundly affecting the quality of life. Its prevalence among newly diagnosed Graves' patients seems to be declining, at least as far as moderate-to-severe forms are...

  • Increased Bone Alkaline Phosphatase and Isolated Subcortical Bone Uptake of Technetium-99m Hydroxymethylene Diphosphonate in the Lower Extremities in a Patient with Graves' Disease: A Distinctly Unusual Variant of Graves' Acropachy.  // Thyroid;Nov2008, Vol. 18 Issue 11, p1227 

    Background:Thyroid acropachy is an extreme manifestation of autoimmune thyroid disease characterized by soft tissue swelling and periosteal bone changes, usually occurring in the fingers, toes, and lower extremities. Here, a patient with a distinctly unusual variant of thyroid acropachy is...

  • Premature twins of a mother with Graves' disease with discordant thyroid function: a case report. O'Connor, M. J.; Paget-Brown, A. O.; Clarke, W. L. // Journal of Perinatology;Jun2007, Vol. 27 Issue 6, p388 

    Thyroid dysfunction is recognized in the newborns of mothers affected by Graves' disease during pregnancy. We describe the development of concurrent hyperthyroidism and hypothyroidism in the twin infants of a mother with Graves' disease diagnosed during pregnancy.

  • Clinical Studies of Exposure to Perchlorate in the United States. Lewis E. Braverman // Thyroid;Sep2007, Vol. 17 Issue 9, p819 

    Perchlorate is a competitive inhibitor of the sodium/iodine symporter, decreasing the active transport of iodine into the thyroid. It was used as an antithyroid drug in the treatment of hyperthyroidism in the 1950s and 1960s but was discontinued because of the occasional occurrence of aplastic...

Share

Read the Article

Courtesy of THE LIBRARY OF VIRGINIA

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics